Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review

被引:5
|
作者
Layard Horsfall, Hugo [1 ,2 ,3 ,4 ]
Lawrence, Alistair [5 ]
Venkatesh, Ashwin
Loh, Ryan T. S.
Jayapalan, Ronie [1 ,2 ]
Koulouri, Olympia [6 ,7 ,8 ,9 ]
Sharma, Rishi [2 ,10 ]
Santarius, Thomas [1 ,2 ]
Gurnell, Mark [6 ,7 ,8 ,9 ]
Dorward, Neil [3 ]
Mannion, Richard [1 ,2 ]
Marcus, Hani J. [3 ,4 ]
Kolias, Angelos G. [1 ,2 ]
机构
[1] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England
[2] Univ Cambridge, Cambridge, England
[3] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Queen Sq, London W1CN 3BG, England
[4] UCL, Wellcome EPSRC Ctr Intervent & Surg Sci, London, England
[5] Royal London Hosp, Dept Neurosurg, London, England
[6] Univ Cambridge, Clin Sch Med, Cambridge, England
[7] Inst Metab Sci, Metab Res Labs, Cambridge, England
[8] Univ Cambridge, Dept Med, Cambridge, England
[9] Addenbrookes Hosp, Cambridge, England
[10] Addenbrookes Hosp, Dept Otolaryngol, Cambridge, England
基金
英国惠康基金; 英国工程与自然科学研究理事会;
关键词
Neurosurgery; Pituitary; Transsphenoidal; Outcome; Adenoma; Core outcome sets; INSTITUTE;
D O I
10.1007/s11102-023-01303-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeTranssphenoidal surgery is an established treatment for pituitary adenomas. We examined outcomes and time points following transsphenoidal surgery for pituitary adenoma to identify reporting heterogeneity within the literature.MethodsA systematic review of studies that reported outcomes for transsphenoidal surgery for pituitary adenoma 1990-2021 were examined. The protocol was registered a priori and adhered to the PRISMA statement. Studies in English with > 10 patients (prospective) or > 500 patients (retrospective) were included.Results178 studies comprising 427,659 patients were included. 91 studies reported 2 or more adenoma pathologies within the same study; 53 studies reported a single pathology. The most common adenomas reported were growth hormone-secreting (n = 106), non-functioning (n = 101), and ACTH-secreting (n = 95); 27 studies did not state a pathology. Surgical complications were the most reported outcome (n = 116, 65%). Other domains included endocrine (n = 104, 58%), extent of resection (n = 81, 46%), ophthalmic (n = 66, 37%), recurrence (n = 49, 28%), quality of life (n = 25, 19%); and nasal (n = 18, 10%). Defined follow up time points were most reported for endocrine (n = 56, 31%), extent of resection (n = 39, 22%), and recurrence (n = 28, 17%). There was heterogeneity in the follow up reported for all outcomes at different time points: discharge (n = 9), < 30 days (n = 23), < 6 months (n = 64), < 1 year (n = 23), and > 1 year (n = 69).ConclusionOutcomes and follow up reported for transsphenoidal surgical resection of pituitary adenoma are heterogenous over the last 30 years. This study highlights the necessity to develop a robust, consensus-based, minimum, core outcome set. The next step is to develop a Delphi survey of essential outcomes, followed by a consensus meeting of interdisciplinary experts. Patient representatives should also be included. An agreed core outcome set will enable homogeneous reporting and meaningful research synthesis, ultimately improving patient care.
引用
下载
收藏
页码:171 / 181
页数:11
相关论文
共 50 条
  • [31] Severe hyponatremia after transsphenoidal surgery for pituitary adenomas
    Boehnert, M
    Hensen, J
    Henig, A
    Fahlbusch, R
    Gross, P
    Buchfelder, M
    KIDNEY INTERNATIONAL, 1998, : S12 - S14
  • [32] Microscopic Transnasal Transsphenoidal Surgery for Pediatric Pituitary Adenomas
    Jiao, Wei
    Huang, Yimin
    Sun, Wei
    Lei, Ting
    JOURNAL OF CRANIOFACIAL SURGERY, 2017, 28 (04) : 1010 - 1012
  • [33] Outcomes of intraoperative ultrasound for endoscopic endonasal transsphenoidal pituitary surgery in adenomas with parasellar extension
    Domino, Joseph S.
    Gattozzi, Domenico A.
    Jack, Megan
    Carroll, Melissa
    Harn, Nick
    Beahm, D. David
    Chamoun, Roukoz
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2021, 25
  • [34] Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: outcomes with Cushing’s disease
    Sauradeep Sarkar
    Simon Rajaratnam
    Geeta Chacko
    Sunithi Mani
    Asha S. Hesargatta
    Ari George Chacko
    Acta Neurochirurgica, 2016, 158 : 77 - 86
  • [35] SURGICAL OUTCOMES OF PITUITARY ADENOMAS TREATED WITH TRANSSPHENOIDAL SURGERY: A SINGLE INSTITUTION'S EXPERIENCE
    Seo, Young Beom
    Kim, Oh-Lyong
    NEURO-ONCOLOGY, 2019, 21 : 241 - 241
  • [36] Pure endoscopic transsphenoidal surgery for functional pituitary adenomas: outcomes with Cushing's disease
    Sarkar, Sauradeep
    Rajaratnam, Simon
    Chacko, Geeta
    Mani, Sunithi
    Hesargatta, Asha S.
    Chacko, Ari George
    ACTA NEUROCHIRURGICA, 2016, 158 (01) : 77 - 86
  • [37] Outcomes of Endoscopic Transsphenoidal Pituitary Surgery
    Dallapiazza, Robert F.
    Jane, John A., Jr.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2015, 44 (01) : 105 - +
  • [38] Current and Future Perspectives of Microscopic and Endoscopic Transsphenoidal Surgery for Pituitary Adenomas: A Narrative Review
    Guinto, Gerardo
    Guinto-Nishimura, Gerardo Y.
    V. Sangrador-Deitos, Marcos
    Uribe-Pacheco, Rodrigo
    Soto-Martinez, Rene
    Gallardo, David
    Guinto, Patricia
    Vargas, Alejandro
    Arechiga, Norma
    ARCHIVES OF MEDICAL RESEARCH, 2023, 54 (08)
  • [39] Surgical Outcomes Following Repeat Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas: A Retrospective Comparative Study
    Bakhsheshian, Joshua
    Wheeler, Sarah
    Strickland, Ben A.
    Pham, Martin H.
    Rennert, Robert C.
    Carmichael, John
    Weiss, Martin
    Zada, Gabriel
    OPERATIVE NEUROSURGERY, 2019, 16 (02) : 127 - 135
  • [40] DDAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas
    Sheehan, JM
    Sheehan, JP
    Douds, GL
    Page, RB
    ACTA NEUROCHIRURGICA, 2006, 148 (03) : 287 - 291